Legacy CG LLC Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Legacy CG LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,367 shares of the healthcare conglomerate’s stock after purchasing an additional 452 shares during the period. UnitedHealth Group makes up approximately 1.9% of Legacy CG LLC’s portfolio, making the stock its 22nd biggest holding. Legacy CG LLC’s holdings in UnitedHealth Group were worth $4,931,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Keel Point LLC boosted its position in UnitedHealth Group by 4.6% during the fourth quarter. Keel Point LLC now owns 4,011 shares of the healthcare conglomerate’s stock worth $2,112,000 after purchasing an additional 176 shares in the last quarter. Bourgeon Capital Management LLC lifted its position in shares of UnitedHealth Group by 385.7% in the fourth quarter. Bourgeon Capital Management LLC now owns 5,226 shares of the healthcare conglomerate’s stock valued at $2,751,000 after acquiring an additional 4,150 shares in the last quarter. Sentry Investment Management LLC lifted its position in shares of UnitedHealth Group by 5.6% in the fourth quarter. Sentry Investment Management LLC now owns 5,679 shares of the healthcare conglomerate’s stock valued at $2,990,000 after acquiring an additional 300 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of UnitedHealth Group by 8.8% in the fourth quarter. Mackenzie Financial Corp now owns 701,165 shares of the healthcare conglomerate’s stock valued at $369,142,000 after acquiring an additional 56,694 shares in the last quarter. Finally, Invesco LLC increased its stake in UnitedHealth Group by 2.9% in the fourth quarter. Invesco LLC now owns 1,103 shares of the healthcare conglomerate’s stock valued at $581,000 after purchasing an additional 31 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Stephens restated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $573.80.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $7.26 during midday trading on Monday, reaching $446.46. 3,847,458 shares of the company were exchanged, compared to its average volume of 4,281,568. The stock’s 50-day moving average price is $492.29 and its 200-day moving average price is $516.34. The stock has a market cap of $411.60 billion, a P/E ratio of 18.74, a PEG ratio of 1.20 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter in the previous year, the firm posted $5.34 earnings per share. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.